Index of reports
> Cases with Maternal Drugs Affecting Foetus (6)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Sumatriptan where reactions include maternal drugs affecting foetus. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Sumatriptan side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-14
Patient: male
Reactions: Cytogenetic Abnormality, Dysmorphism, Maternal Drugs Affecting Foetus, Glaucoma, Pneumonia Aspiration, Micrognathia, Pierre Robin Syndrome, Caesarean Section, Cleft Palate, Developmental Delay, Respiratory Disorder Neonatal, Laryngomalacia, Gastrooesophageal Reflux Disease, Myopia, Ear Infection, Torticollis, Deafness Congenital, Respiratory Distress, Hyperbilirubinaemia Neonatal, Craniosynostosis, Bronchial Hyperreactivity, Respiratory Tract Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Codeine Phosphate, Guaifenesin (Cheracol / 00693301 / )
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Olopatadine Hydrochloride
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Nitrofurantoin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Cetirizine
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Azithromycin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Topiramate
Dosage: 50 mg (25 mg, 2 in 1 d), transplacental
Indication: Migraine
Start date: 2010-03-15
End date: 2010-04-15
Amoxicillin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Ibuprofen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Hydrocodone Bitartrate and Acetaminophen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Sumatriptan
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Fluticasone Propionate
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Cyclobenzaprine
Dosage: 30 mg (10 mg, 3 in 1 d), transplacental
Indication: Sciatic Nerve Injury
Naproxen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Prenatal Vitamins (Prenatal Viotamins / 01549301 / )
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Possible Sumatriptan side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-04
Patient: male
Reactions: Hyperbilirubinaemia, Maternal Drugs Affecting Foetus, Cytogenetic Abnormality, Glaucoma, Pierre Robin Syndrome, Deafness, Micrognathia, Body Dysmorphic Disorder, Cleft Palate, Caesarean Section, Developmental Delay, Cough, Dyspnoea, Chest Discomfort, Myopia, Craniosynostosis, Bronchial Hyperreactivity
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclobenzaprine
Dosage: 30 mg (10 mg, 3 in 1 d), transplacental
Indication: Sciatic Nerve Injury
Amoxicillin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Topiramate
Dosage: 50;100;1w mg (25 mg, 2 in 1 d), transplacental
Indication: Migraine
Naproxen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Sumatriptan
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Nitrofurantoin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Hydrocodone Bitartrate and Acetaminophen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Prenatal Vitamins (Prenatal Vitamins (01549301)
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Fluticasone Propionate
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Azithromycin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Ibuprofen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Cetirizine
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Codeine Phosphate, Guaifenesin (Cheracol / 00693301 / )
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Olopatadine Hydrochloride
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Possible Sumatriptan side effects in
Reported by a physician from Canada on 2012-04-05
Patient:
Reactions: Foetal Growth Restriction, Hypoglycaemia Neonatal, Maternal Drugs Affecting Foetus, Foetal Exposure During Pregnancy, Hypoglycaemia
Drug(s) suspected as cause:
Pantoprazole
Ondansetron
Indication: Hyperemesis Gravidarum
Oxazepam
Hydroxyzine
Dosage: 25mg four times per day
Indication: Hyperemesis Gravidarum
Diphenhydramine HCL
Dosage: 50mg four times per day
Indication: Hyperemesis Gravidarum
Metoclopramide
Indication: Hyperemesis Gravidarum
Cosyntropin
Humulin R
Sumatriptan
Aspirin
Thiamine HCL
Indication: Hyperemesis Gravidarum
Multi-Vitamins
Indication: Hyperemesis Gravidarum
Hydromorphone HCL
Insulin Aspart
Possible Sumatriptan side effects in female
Reported by a individual with unspecified qualification from Germany on 2012-04-04
Patient: female, weighing 2.7 kg (5.9 pounds)
Reactions: Maternal Drugs Affecting Foetus, Bradycardia Neonatal, Infantile Apnoeic Attack
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sumatriptan
Possible Sumatriptan side effects in
Reported by a physician from Germany on 2012-03-30
Patient:
Reactions: Maternal Drugs Affecting Foetus, Bradycardia Neonatal, Infantile Apnoeic Attack
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sumatriptan
Possible Sumatriptan side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-26
Patient: female, weighing 2.7 kg (5.9 pounds)
Reactions: Maternal Drugs Affecting Foetus, Bradycardia Neonatal, Infantile Apnoeic Attack
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sumatriptan
|